• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IScore 是一种有用的预后工具,可用于接受静脉溶栓治疗的急性缺血性脑卒中患者:一项验证研究。

IScore, a useful prognostic tool for patients with acute ischemic stroke treated with intravenous thrombolysis: a validation study.

机构信息

Universidade Federal do Paraná, Hospital de Clínicas, Divisão de Neurologia, Curitiba PR, Brasil.

出版信息

Arq Neuropsiquiatr. 2023 Feb;81(2):107-111. doi: 10.1055/s-0042-1758397. Epub 2023 Mar 22.

DOI:10.1055/s-0042-1758397
PMID:36948196
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10033190/
Abstract

BACKGROUND

Stroke is one of the major causes of disability and mortality worldwide. Up to 30% of individuals who experience stroke die within 30 days, and more than 50% of those who survive will have some degree of disability. There are some predetermining factors based on admission data that could be used to objectively assess the odds of poor outcomes, including the Ischemic Stroke Predictive Risk Score (IScore).

OBJECTIVE

To analyze and validate the IScore in patients undergoing intravenous thrombolysis for stroke and compare the results of this predictor with actual death and disability outcomes.

METHODS

In a retrospective study, data were collected from a database housed at the Stroke Unit of the Teaching Hospital of Universidade Federal do Paraná, Southern Brazil. The IScore was applied to admission data from 239 patients, and the results were compared with actual outcomes (death and disability) within 30 days and 1 year after the stroke event. Data analysis was performed using an analysis of the receiver operating characteristic (ROC) curve to determine the sensitivity and specificity of the IScore in the study population.

RESULTS

The IScore demonstrated moderate sensitivity and high specificity in patients with stroke who underwent thrombolysis when evaluated after 30 days and 1 year of the event.

CONCLUSIONS

The IScore can be applied to in stroke patients undergoing thrombolysis; therefore, it may be used as an objective prognostic tool to guide clinical decision-making. Understanding the prognosis of patients in the acute phase can assist clinicians in making the best therapeutic decisions and enable better end-of-life care.

摘要

背景

中风是全球范围内导致残疾和死亡的主要原因之一。多达 30%的中风患者在 30 天内死亡,超过 50%的幸存者将有一定程度的残疾。根据入院数据有一些预测因素,可以客观地评估不良预后的可能性,包括缺血性中风预测风险评分(IScore)。

目的

分析和验证接受静脉溶栓治疗的中风患者的 IScore,并将该预测因子的结果与实际死亡和残疾结果进行比较。

方法

在一项回顾性研究中,从巴西南部联邦大学教学医院中风科的数据库中收集数据。将 IScore 应用于 239 名患者的入院数据,并将结果与中风事件后 30 天和 1 年内的实际结局(死亡和残疾)进行比较。使用接收器操作特性(ROC)曲线分析对数据进行分析,以确定 IScore 在研究人群中的敏感性和特异性。

结果

IScore 在接受溶栓治疗的中风患者中,在事件发生后 30 天和 1 年评估时,具有中度敏感性和高特异性。

结论

IScore 可应用于接受溶栓治疗的中风患者;因此,它可以作为一种客观的预后工具,指导临床决策。了解急性期患者的预后情况可以帮助临床医生做出最佳治疗决策,并为临终关怀提供更好的支持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/204c/10033190/9fdc76ee77fa/10-1055-s-0042-1758397-i220037-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/204c/10033190/f52b3da8045f/10-1055-s-0042-1758397-i220037-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/204c/10033190/1258a3d6e140/10-1055-s-0042-1758397-i220037-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/204c/10033190/9fdc76ee77fa/10-1055-s-0042-1758397-i220037-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/204c/10033190/f52b3da8045f/10-1055-s-0042-1758397-i220037-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/204c/10033190/1258a3d6e140/10-1055-s-0042-1758397-i220037-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/204c/10033190/9fdc76ee77fa/10-1055-s-0042-1758397-i220037-3.jpg

相似文献

1
IScore, a useful prognostic tool for patients with acute ischemic stroke treated with intravenous thrombolysis: a validation study.IScore 是一种有用的预后工具,可用于接受静脉溶栓治疗的急性缺血性脑卒中患者:一项验证研究。
Arq Neuropsiquiatr. 2023 Feb;81(2):107-111. doi: 10.1055/s-0042-1758397. Epub 2023 Mar 22.
2
The Prognostic Value of the THRIVE Score, the iScore Score and the ASTRAL Score in Chinese Patients With Acute Ischemic Stroke.THRIVE评分、iScore评分和ASTRAL评分在中国急性缺血性脑卒中患者中的预后价值
J Stroke Cerebrovasc Dis. 2018 Oct;27(10):2877-2886. doi: 10.1016/j.jstrokecerebrovasdis.2018.06.011. Epub 2018 Aug 2.
3
Predicting clinical outcomes after thrombolysis using the iScore: results from the Virtual International Stroke Trials Archive.基于 iScore 预测溶栓治疗后的临床结局:来自虚拟国际卒中试验档案的结果。
Stroke. 2013 Oct;44(10):2755-9. doi: 10.1161/STROKEAHA.113.001343. Epub 2013 Jul 25.
4
The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke.iScore 预测急性缺血性脑卒中溶栓治疗的效果。
Stroke. 2012 May;43(5):1315-22. doi: 10.1161/STROKEAHA.111.646265. Epub 2012 Feb 3.
5
The iScore predicts clinical response to tissue plasminogen activator in Korean stroke patients.iScore 可预测韩国脑卒中患者对组织型纤溶酶原激活物的临床反应。
J Stroke Cerebrovasc Dis. 2014 Feb;23(2):367-73. doi: 10.1016/j.jstrokecerebrovasdis.2013.05.025. Epub 2013 Jun 22.
6
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.急性缺血性脑卒中动脉内脑溶栓的试验设计与报告标准。
Stroke. 2003 Aug;34(8):e109-37. doi: 10.1161/01.STR.0000082721.62796.09. Epub 2003 Jul 17.
7
The iScore predicts poor functional outcomes early after hospitalization for an acute ischemic stroke.iScore 可预测急性缺血性脑卒中住院后早期的不良功能结局。
Stroke. 2011 Dec;42(12):3421-8. doi: 10.1161/STROKEAHA.111.623116. Epub 2011 Sep 29.
8
Revised iScore to predict outcomes after acute ischemic stroke.用于预测急性缺血性卒中后预后的改良iScore。
J Stroke Cerebrovasc Dis. 2014 Jul;23(6):1634-9. doi: 10.1016/j.jstrokecerebrovasdis.2014.01.010. Epub 2014 Apr 5.
9
Stroke Prognostic Scores and Data-Driven Prediction of Clinical Outcomes After Acute Ischemic Stroke.中风预后评分和急性缺血性中风后临床结局的数据驱动预测。
Stroke. 2020 May;51(5):1477-1483. doi: 10.1161/STROKEAHA.119.027300. Epub 2020 Mar 25.
10
The Prognostic Value of the iScore, the PLAN Score, and the ASTRAL Score in Acute Ischemic Stroke.iScore、PLAN评分及ASTRAL评分在急性缺血性卒中中的预后价值
J Stroke Cerebrovasc Dis. 2017 Jun;26(6):1233-1238. doi: 10.1016/j.jstrokecerebrovasdis.2017.01.013. Epub 2017 Feb 22.

本文引用的文献

1
30-day and 60-day rates and predictors of mortality among adult stroke patients: Prospective cohort study.成年中风患者30天和60天死亡率及预测因素:前瞻性队列研究。
Ann Med Surg (Lond). 2020 Mar 21;53:1-11. doi: 10.1016/j.amsu.2020.03.001. eCollection 2020 May.
2
Public hospitalizations for stroke in Brazil from 2009 to 2016.巴西 2009 年至 2016 年的脑卒中住院治疗情况。
PLoS One. 2019 Mar 19;14(3):e0213837. doi: 10.1371/journal.pone.0213837. eCollection 2019.
3
Stroke in the 21 Century: A Snapshot of the Burden, Epidemiology, and Quality of Life.
21世纪的中风:负担、流行病学及生活质量概览
Stroke Res Treat. 2018 Nov 27;2018:3238165. doi: 10.1155/2018/3238165. eCollection 2018.
4
Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010.1990-2010 年全球及各区域卒中负担变化:来自 2010 年全球疾病负担研究的结果。
Lancet. 2014 Jan 18;383(9913):245-54. doi: 10.1016/s0140-6736(13)61953-4.
5
JURaSSiC: accuracy of clinician vs risk score prediction of ischemic stroke outcomes.JURaSSiC:临床医生与风险评分预测缺血性脑卒中结局的准确性。
Neurology. 2013 Jul 30;81(5):448-55. doi: 10.1212/WNL.0b013e31829d874e. Epub 2013 Jun 28.
6
ASTRAL score predicts 5-year dependence and mortality in acute ischemic stroke.ASTRAL 评分可预测急性缺血性脑卒中 5 年内的依赖和死亡率。
Stroke. 2013 Jun;44(6):1616-20. doi: 10.1161/STROKEAHA.113.001047. Epub 2013 Apr 4.
7
Stroke Prognostication using Age and NIH Stroke Scale: SPAN-100.使用年龄和 NIH 卒中量表预测卒中预后:SPAN-100。
Neurology. 2013 Jan 1;80(1):21-8. doi: 10.1212/WNL.0b013e31827b1ace. Epub 2012 Nov 21.
8
Symptomatic intracranial hemorrhage after stroke thrombolysis: the SEDAN score.症状性颅内出血后溶栓治疗的 SEDAN 评分。
Ann Neurol. 2012 May;71(5):634-41. doi: 10.1002/ana.23546.
9
Predicting outcome of IV thrombolysis-treated ischemic stroke patients: the DRAGON score.预测接受 IV 溶栓治疗的缺血性脑卒中患者结局:DRAGON 评分。
Neurology. 2012 Feb 7;78(6):427-32. doi: 10.1212/WNL.0b013e318245d2a9.
10
The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke.iScore 预测急性缺血性脑卒中溶栓治疗的效果。
Stroke. 2012 May;43(5):1315-22. doi: 10.1161/STROKEAHA.111.646265. Epub 2012 Feb 3.